It is understood that there are about 1/3 of people suffering from cardiovascular and cerebrovascular in the world,15 million people died of cardiovascular every year,which accounted for 3/5 among the deaths.China is the country that has the highest incidence of cardiovascular in the world.It is indispensable to develop new plant extracts to treat cardiovascular diseases.
According to the pharmacological effects of hawthorn, now there are many hawthorn compounds used in the treatment of hyperlipidemia, coronary heart disease, angina, arrhythmias and other cardiovascular diseases. In addition, hawthorn can also protect the retina,inhibit distortion,treat Chyluria, hiccups, vocal cord polyps, lower extremity soft tissue injury, psoriasis, neurodermatitis and so on.
As an effective functional product,hawthorn flavonoids has been widely added to many kinds of liquor, juice, vinegar, yogurt.
With the promotion of public health nutrition and traditional Chinese medicine,the growing number of FMCG companies will pay more attention to the product innovation of hawthorn, which will bring greater application opportunities on the market.
There are only thirty to four production enterprises in domestic.the price is relatively stable due to the market demand,its efficacy has not yet been widely recognized in the international market,but the German research recognized the hawthorn flavonoids'effect on heart health.
The development of hawthorn flavonoids in China need plant extract enterprises and domestic FMCG companies to jointly promote,
As edible medicine products,hawthorn is very easy to accept by majority of Chinese consumers, while the hawthorn flavonoids have the real effect,so it's with a good prospect.
Copyright:Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year